Filing Flows › Bioventus (BVS) › Recalls, complaints & regulation
Bioventus (BVS): clinical trials
Bioventus (BVS) beyond its filings: 1 active clinical trial.
Bioventus' latest quarter
Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Bioventus have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.